Inogen | INGN - Net Income


Inogen reported $-5.96M in Net Income for its fiscal quarter ending in September of 2024.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Accuray USD 2.54M 6.49M Dec/2024
AngioDynamics USD -6.35M 4.55M Sep/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 108K 1.65M Mar/2026
Baxter International USD -15M 1.11B Mar/2026
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Boston Scientific USD 1.34B 669M Mar/2026
Chart Industries USD 53.6M 198.9M Dec/2025
Cooper Companies USD 130.8M 46.2M Dec/2025
Dexcom USD 199.5M 67.8M Mar/2026
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Globus Medical USD 140.59M 21.63M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 91.1M 10.5M Mar/2026
Masimo USD 68.3M 168.7M Dec/2025
Medtronic USD 1.14B 231M Dec/2025
Orthofix International USD -2.22M 20.57M Dec/2025
Philips EUR 151M 244M Mar/2026
ResMed USD 398.73M 6.14M Mar/2026
Steris USD 192.9M 1000K Dec/2025
Stryker USD 745M 104M Mar/2026
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -714.33M 305.44M Dec/2025
X T L Biopharmaceuticals USD -255K 298K Dec/2024
Zimmer Biomet Holdings USD 238.1M 98.8M Mar/2026